These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32432847)

  • 1. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
    Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
    Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
    Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
    Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma targeting peptide modified apoferritin nanocage.
    Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
    Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
    Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
    Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.
    Guo X; Wu G; Wang H; Chen L
    J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment.
    Mendes M; Nunes S; Cova T; Branco F; Dyrks M; Koksch B; Vale N; Sousa J; Pais A; Vitorino C
    Colloids Surf B Biointerfaces; 2024 Sep; 241():113983. PubMed ID: 38850741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin α
    Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
    J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis.
    Zheng MZ; Yang ZQ; Cai SL; Zheng LT; Xue Y; Chen L; Lin J
    Lung Cancer; 2024 Oct; 196():107957. PubMed ID: 39303402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
    Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
    Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
    Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
    Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.
    Brighi C; Reid L; Genovesi LA; Kojic M; Millar A; Bruce Z; White AL; Day BW; Rose S; Whittaker AK; Puttick S
    Theranostics; 2020; 10(14):6361-6371. PubMed ID: 32483457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.